forian provides a unique suite of saas solutions, data management capabilities and proprietary data and analytics to optimize and measure operational, clinical and financial performance for customers within the traditional and emerging life sciences, healthcare payer and provider segments, as well as cannabis dispensaries, manufacturers, cultivators and regulators.

Sector

Information

Industry

Data Processing, Hosting, and Related Services

CEO

Zachary Venegas

helixtcs.com/ →

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Alerts

News

Work From Home, Carpool and Fly Less to Combat Soaring Oil Prices, IEA Says

Why is Planet Labs' stock soaring?

Airline and hospitality stocks lift FTSE 100 as oil price retreats

Best Income Stocks to Buy for March 20th

NAVN Investors Have Opportunity to Lead Navan, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Stock Market Today: Oil Steadies as Israel Signals Restraint

ENPH Investors Have Opportunity to Lead Enphase Energy, Inc. Securities Fraud Lawsuit with the Schall Law Firm

SS&C GlobeOp Forward Redemption Indicator

CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm

Atlantic Lithium cheers "watershed moment" as Ewoyaa lithium project's mining lease is ratified

Is Apple Stock Your Ticket to Becoming a Millionaire?

S&P Global: I Believe Artificial Intelligence Is A Blessing Rather Than A Curse

QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm

Canadian Apartment Properties: A Record Discount To NAV; Buy

Arrow Exploration looks forward to a continuation successful, low risk drilling campaign

Scholastic Has A New Lease On Life (Rating Upgrade)

Deutsche Lufthansa AG: Mr Carsten Spohr, Acquisition

PSFE Investors Have Opportunity to Lead Paysafe Limited Securities Fraud Lawsuit with the Schall Law Firm

4 Dividend Stocks to Hold for the Next 10 Years

SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

About